medigraphic.com
ISSN 0035-0052 (Print)

2021, Number 6

<< Back Next >>

Rev Mex Pediatr 2021; 88 (6)

Neuropsychological profile of a patient with late infantile Krabbe disease and visual agnosia

Robles-Bermejo F, Fournier-del CMC, Gutiérrez-Solana LG, López-Marín L

Language: Spanish
References: 18
Page: 244-248
PDF size: 243.61 Kb.


ABSTRACT

Krabbe disease is a type of autosomal recessive lysosomal leukodystrophy caused by deficiency of the enzyme galactosylceramidase. The results of the neuropsychological evaluation in a three-year-old boy with apperceptive visual agnosia and prosopagnosia are presented.


REFERENCES

  1. Mikulka CR, Sands MS. Treatment for Krabbe's disease: finding the combination. J Neurosci Res. 2016; 94(11): 1126-1137.

  2. Duffner PK, Jalal K, Carter RL. The Hunter's hope Krabbe family database. Pediatr Neurol. 2009; 40(1): 13-18.

  3. Shapiro EG, Klein KA. Dementia in childhood: issues in neuropsychological assessment with application to the natural history and treatment of degenerative storage diseases. In: Tramontana MG, Hooper SR, eds. Advances in child neuropsychology (vol. 2). New York: Springer-Verlag; 1994. pp. 119-171.

  4. Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL. Early infantile Krabbe disease: results of the world-wide Krabbe registry. Pediatr Neurol. 2011; 45(3): 141-148.

  5. Duffner PK, Barczykowski A, Kay DM et al. Later onset phenotypes of Krabbe disease: result s of the world-wide Krabbe registry. Pediatr Neurol. 2012; 46(5): 298-306.

  6. Jalal K, Carter RL, Yan L, Barczykowski A, Duffner PK. The effect of galactocerebrosidase (GALC) activity on age of symptom onset in Krabbe disease (KD). Mol Genet Metab. 2011; 102(Suppl.): S22.

  7. Gelinas J, Liao P, Lehman A et al. Child Neurology: Krabbe disease: a potentially treatable white matter disorder. Neurology. 2012; 79(19): 170-172.

  8. Lantos JD. Dangerous and expensive screening and treatment for rare childhood diseases: the case of Krabbe disease. Dev Disabil Res Rev. 2011; 17: 15-18.

  9. Orsini JJ, Escolar ML, Wasserstein MP et al. Krabbe disease. 2000 Jun 19 [Updated 2018 Oct 11]. In: Adam MP, Ardinger HH, Pagon RA et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.

  10. Kim SU. Lysosomal storage diseases: stem cell-based cell- and gene-therapy. Cell Trasplant. 2014. doi: 10.3727/096368914X681946.

  11. Farah MJ. Visual agnosia. 2a ed. Cambridge: MIT press/Bradford Books; 2004.

  12. De Renzi E. Agnosia. In: Denes G, Pizzamiglio L (eds). Handbook of clinical and experimental neuropsychology. Reino Unido: Psychology Press; 1999. pp. 371-408.

  13. García-García R, Cacho-Gutiérrez LJ. Prosopagnosia ¿entidad única o múltiple? Rev Neurol. 2004; 38: 682-686.

  14. Thusang K, Khalil S. Progressive cognitive decline and gait instability in a four year old boy. Pediatr Neurol. 2019; 99: 92-93.

  15. Zárate-Aspiros R, Sosa-Sánchez AD, Rosas-Sumano AB et al. Enfermedad de Krabbe. Reporte de un caso. Rev Mex Pediatr. 2016; 83(6): 198-202.

  16. Klein KA, Shapiro EG. Visual agnosia in children: a new and different look. J Clin Exp Neuropsychol. 1992; 14: 108.

  17. Fournier MC. Neuropsicología de las demencias infantiles: Adrenoleucodistrofia ligada a X. Ruano A (Ed). Neuropsicología Infantil. Madrid: Editorial Mafre; 2002. pp. 337-358.

  18. Schoenberg MR, Scott JG. Cognitive decline in childhood or young adult. In: Schoenberg MR, Scott JG, eds. The little black book of neuropsychology. New York: Springer; 2011. pp. 839-861.




2020     |     www.medigraphic.com